|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Is High Cardiorespiratory Fitness Associated With Longer Lifespan, Lower Multimorbidity?Higher cardiorespiratory fitness (CRF) was associated with longer lifespan, longer health span and lower multimorbidity in both women and men, according to a cohort study using participants from the Cooper Center Longitudinal Study (CCLS) and published April 22 in JACC.
- ACC.26 Structural Intervention Trials Offer Viable OptionsLate-breaking clinical trials presented at ACC.26 focusing on structural interventions included the PROTECT H2H trial comparing two embolic protection devices (EPDs) in patients undergoing transcatheter aortic valve implantation (TAVI), the PRO-TAVI trial comparing a strategy of routine PCI with a deferred approach...
- CHAMPION-AF: An Uneasy Win For Watchman DeviceThe CHAMPION-AF trial randomized 3,000 patients with nonvalvular atrial fibrillation (AFib) (mean age, 72 years; mean CHA2DS2-VASc score, 3.5; mean HAS-BLED score, 1.3) who were suitable for long-term oral anticoagulation to either left atrial appendage closure (LAAC) (Watchman Flx, Boston Scientific) or non–vitamin K antagonist oral anticoagulants (NOACs).
- New Advanced Training Statement Revises Core Competencies For CCEPA new Advanced Training Statement developed by the ACC, AHA and the Heart Rhythm Society outlines the core competencies required of subspecialists in clinical cardiac electrophysiology (CCEP) to optimally diagnosis and treat patients with cardiac arrhythmias and conduction disturbances.
- Noninvasive Assessment of Myocardial Fibroblast Activation May Improve Phenotyping, Risk Stratification For HFrEFPersistent activation of myocardial fibroblasts was observed in patients with heart failure with reduced ejection fraction (HFrEF), with distinct spatial patterns related to the etiology of the cardiomyopathy, according to results from a prospective study published April 15 in JAMA Cardiology.



